Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted
Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCMKTS: DMTTF) have completed their August acquisition agreement. Following their arrangement plan under the BC business Corporations Act, and pursuant to the agreement’s terms, Small Pharma is now a wholly-owned subsidiary of Cybin. Read all the details HERE.
Meanwhile, the new combined company’s deuterated psychedelics programs has recently received two patent grants from the United States Patent and Trademark Office (USPTO,) and one from the European Patent Office (EP.) Learn more about the new IP protections HERE.
Elon Musk And Vivek Ramaswamy Warn Of WW III In Discussion About Ukraine, Russia, China & Peace
Vivek Ramaswamy, the only major Republican presidential candidate to publicly support legalizing marijuana and moving toward regulating access to certain psychedelics, is not unlike his friend and supporter Tesla (NASDAQ: TSLA) CEO Elon Musk who has also been forthcoming about psychedelic drugs and their benefits.
Though Ramaswamy bounded into national recognition following the recent Trump-less debates, the 38-year-old tech entrepreneur has not been outspoken at those debates about his support for cannabis policy reform, unlike Musk, who has said psychedelics should be seriously considered for therapeutic uses. Keep reading HERE.
Britney's Memoir Decoded: Drugs, Depression And Drama With Timberlake
It isn't every day that the veil is lifted off a global superstar's life, revealing vulnerable crevices and raw emotions, especially not from the "Princess of Pop," Britney Spears. Her memoir, "The Woman in Me," is a treasure trove of disclosures, rendering insights into the tumultuous ride she experienced under the glaring limelight.
Pop culture aficionados would recall the iconic shaved head, the umbrella rage and the infamous paparazzi moments. However, Britney's story wasn't just about public meltdowns. At the heart of ...